Therapeutic Asset Ratings

278 results matching 1 filter

129,767 assets · 8,707 sponsors · 3,128 indications

Methodology v0.2

Asset	Sponsor	Phase	Rating
IMMUNOGLOBULIN G1 (HUMAN-RAT MONOCLONAL CAMPATH-1H .GAMMA.1-CHAIN ANTI-HUMAN ANTIGEN CD52), DISULFIDE WITH HUMAN-RAT MONOCLONAL CAMPATH-1H LIGHT CHAIN, DIMER X-Linked Lymphoproliferative Syndrome	Washington University School of Medicine	P2	CCC (53)
Levonorgestrel Endometrial Disorder	Washington University School of Medicine	P2	CCC (53)
Levonorgestrel Endometrial Neoplasm Malignant	Washington University School of Medicine	P2	CCC (53)
Levonorgestrel Endometrial Carcinoma	Washington University School of Medicine	P2	CCC (53)
PANTOPRAZOLE Carcinoma Of The Ampulla Of Vater	Washington University School of Medicine	P2	CCC (53)
PANTOPRAZOLE Distal Biliary Tract Carcinoma	Washington University School of Medicine	P2	CCC (53)
PANTOPRAZOLE Duodenum Cancer	Washington University School of Medicine	P2	CCC (53)
PANTOPRAZOLE Pancreatic Neuroendocrine Tumor	Washington University School of Medicine	P2	CCC (53)
PANTOPRAZOLE Pancreatitis	Washington University School of Medicine	P2	CCC (53)
Pegargiminase Prediabetes Syndrome	Washington University School of Medicine	P2	CCC (53)
Semaglutide Endometrial Disorder	Washington University School of Medicine	P2	CCC (53)
Suvorexant Sleep Disorder	Washington University School of Medicine	P2	CCC (53)
Tazemetostat Mycosis Fungoides/Sezary Syndrome	Washington University School of Medicine	P2	CCC (53)
Tazemetostat T-cell Large Granular Lymphocytic Leukemia	Washington University School of Medicine	P2	CCC (53)
Thiotepa Autoimmune Lymphoproliferative Syndrome	Washington University School of Medicine	P2	CCC (53)
Thiotepa Chediak-Higashi Syndrome	Washington University School of Medicine	P2	CCC (53)
Thiotepa DiGeorge Syndrome	Washington University School of Medicine	P2	CCC (53)
Thiotepa Hyper-IgM Syndrome	Washington University School of Medicine	P2	CCC (53)
Thiotepa Immune Dysregulation-Polyendocrinopathy-Enteropathy-X-Linked Syndrome	Washington University School of Medicine	P2	CCC (53)
Thiotepa Bruton-Type Agammaglobulinemia	Washington University School of Medicine	P2	CCC (53)
TRASTUZUMAB HER2-positive Solid Tumor	Washington University School of Medicine	P2	CCC (53)
TZ-3321 Central Nervous System Cancer	Washington University School of Medicine	P2	CCC (53)
VITAMIN D Dense Breasts	Washington University School of Medicine	P2	CCC (53)
Solanezumab Dementia	Washington University School of Medicine	P2/3	CCC (53)
Avutometinib Pancreatic Adenocarcinoma	Washington University School of Medicine	P2	CCC (51)

Showing 101 to 125 of 278 assets

PreviousPage 5 of 12Next